Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
22.07.2025 20:45:55
|
Johnson & Johnson MedTech, Pacira BioSciences Partner To Promote ZILRETTA For Knee OA Pain
(RTTNews) - Johnson & Johnson MedTech - the medical technology business segment of Johnson & Johnson (JNJ) has entered a strategic co-promotion agreement with Pacira BioSciences, Inc., to expand its Early Intervention portfolio by promoting ZILRETTA, an extended-release injectable suspension for osteoarthritis or OA knee pain.
The collaboration also includes joint professional education and outreach to boost awareness of non-surgical treatment options earlier in the OA care pathway.
Osteoarthritis affects over 30 million U.S. adults, with knee OA being a major cause of pain and mobility issues. While treatments exist, many patients still experience insufficient relief—highlighting a need for longer-lasting, early-stage solutions.
Oray Boston, Worldwide President at Johnson & Johnson MedTech, noted that the partnership aims to ease the burden of OA and help patients access earlier pain relief, while strengthening the company's Early Intervention portfolio.
This initiative aligns with Johnson & Johnson MedTech's broader goal of advancing orthopaedic care through technologies that reflect evolving patient needs and improve outcomes across all stages of disease progression.
ZILRETTA was approved by the FDA in 2017 as the first extended-release intra-articular therapy for OA-related knee pain. It uses proprietary microsphere technology combining triamcinolone acetonide with a PLGA matrix to deliver pain relief lasting up to 12-16 weeks.
JNJ currently trades at $166.98 or 1.59% higher on the NYSE.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
25.09.25 |
Handel in New York: Dow Jones beendet den Handel mit Verlusten (finanzen.at) | |
25.09.25 |
Dow Jones aktuell: Dow Jones gibt zum Start des Donnerstagshandels nach (finanzen.at) | |
23.09.25 |
Dow Jones-Handel aktuell: Dow Jones sackt zum Ende des Dienstagshandels ab (finanzen.at) | |
23.09.25 |
Verluste in New York: Dow Jones präsentiert sich am Nachmittag schwächer (finanzen.at) | |
23.09.25 |
Dow Jones-Handel aktuell: Dow Jones am Dienstagmittag im Aufwind (finanzen.at) | |
19.09.25 |
Pluszeichen in New York: Anleger lassen Dow Jones zum Handelsende steigen (finanzen.at) | |
19.09.25 |
Börse New York in Grün: Dow Jones verbucht am Freitagnachmittag Gewinne (finanzen.at) | |
19.09.25 |
Optimismus in New York: Dow Jones am Freitagmittag auf grünem Terrain (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 151,92 | -0,05% |
|